Global Ocular Drug Delivery Mode Market Analysis, 2020

By Disease Type (Diabetic Retinopathy, Diabetic Macular Edema, Dry Eye Syndrome, Glaucoma, Macular Degeneration, Cataract, Others), By Technology (Topical Iontophoresis, Ocular Ins......ert [Erodible, Non-Erodible], Intraocular Implants [Biodegradable, Non-Biodegradable], In Situ Gel & Punctal Plugs, Others), By Formulation Type (Liposomes & Nanoparticles, Solution, Emulsion, Suspension, Ointment), By End-user (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Homecare Settings), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Brazil, Argentina, UK, Germany, France, Italy, Spain, China, Japan, South Korea, India, South East Asia, UAE, Saudi Arabia, Turkey, South Africa), By Company (Valeant Pharmaceuticals International, Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision Inc., Eyegate Pharma, Clearside Biomedical, Inc., Alimera Sciences, Envisia Therapeutics, Allergan, Plc.) Read more

  • Healthcare
  • Sep 2020
  • 182
  • PDF, Excel, PPT

Ocular drug delivery mode is a technique of treating the eye locally. Global Ocular Drug Delivery Mode Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Ocular Drug Delivery Mode market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

Market Segmentation

According to MarkNtel Advisors’ research report titled “Global Ocular Drug Delivery Mode Market Analysis, 2020”, the Global Ocular Drug Delivery Mode market is anticipated to grow at a CAGR of around 7.5% during 2020-25F. Based on the formulation type, solutions acquired a considerable market share in 2019 owing to its cost-effectiveness, high-patient compliance, and increasing production volume.

Topical Iontophoresis Exhibited Subsequent Growth

Topical Iontophoresis exhibited subsequent growth in the forecast period on account of easy accessibility and the launch of new products with this technology. Moreover, various companies are increasing their presence through mergers and acquisitions of new firms which is expected to proliferate the growth of Ocular Drug Delivery Mode market.

Hospitals Acquired Considerable market share

Based on end user, hospitals acquired the considerable market share in 2019. The rising number of surgeries for eye disorders such as cataract, glaucoma, etc., and burgeoning healthcare spending in the countries such as United States and Canada are anticipated to actively contribute toward the growth of the Ocular Drug Delivery Mode market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Ocular Drug Delivery Mode Market Analysis, 2020”. 

  1. Introduction
    1. Market Segmentation
    2. Product Definition
    3. Research Process
    4. Assumptions
  2. Executive Summary
  3. Impact of Covid-19
  4. Global Ocular Drug Delivery Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Disease Type
        1. Diabetic Retinopathy
        2. Diabetic Macular Edema
        3. Dry Eye Syndrome
        4. Glaucoma
        5. Macular Degeneration
        6. Cataract
        7. Others
      2. By Technology
        1. Topical, Iontophoresis
        2. Ocular Insert
          1. Erodible
          2. Non-Erodible
        3. Intraocular Implants
          1. Biodegradable
          2. Non-Biodegradable
        4. In Situ Gel & Punctal Plugs
        5. Others
      3. Formulation Type
        1. Liposomes & Nanoparticles
        2. Solution
        3. Emulsion
        4. Suspension
        5. Ointment
      4. By End Users
        1. Hospitals
        2. Ophthalmic Clinics
        3. Ambulatory Surgical Centers
        4. Homecare Settings
      5. By Company
        1. Revenue Shares
  5. North America Ocular Drug Delivery Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Disease Type
      2. By Technology
      3. By Formulation
      4. By End Users
      5. By Country
        1. The US
        2. Canada
    3. The United States Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. Canada Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  6. South America Ocular Drug Delivery Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Disease Type
      2. By Technology
      3. By Formulation
      4. By End Users
      5. By Country
        1. Brazil
        2. Argentina
    3. Brazil Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. Argentina Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  7. Europe Ocular Drug Delivery Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Disease Type
      2. By Technology
      3. By Formulation
      4. By End Users
      5. By Country
        1. Germany
        2. France
        3. The UK
        4. Italy
        5. Spain
        6. Others
    3. Germany Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. France Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    5. The UK Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    6. Spain Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    7. Italy Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  8. Asia Pacific Ocular Drug Delivery Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Disease Type
      2. By Technology
      3. By Formulation
      4. By End Users
      5. By Country
        1. China
        2. Japan
        3. South Korea
        4. India
        5. South East Asia
        6. Others
    3. China Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. India Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    5. Japan Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    6. South Korea Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    7. South East Asia Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  9. Middle East & Africa Ocular Drug Delivery Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Disease Type
      2. By Technology
      3. By Formulation
      4. By End Users
      5. By Country
        1. UAE
        2. Saudi Arabia
        3. Turkey
        4. South Africa
        5. Others
    3. UAE Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. Saudi Arabia Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    5. Turkey Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    6. South Africa Ocular Drug Delivery Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  10. Global Ocular Drug Delivery Market Regulations & Policies
  11. Global Ocular Drug Delivery Market Market Trends & Insights
  12. Global Ocular Drug Delivery Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  13. Global Ocular Drug Delivery Market Hotspot & Opportunities
  14. Competition Outlook
    1. Competition Matrix
      1. Product Portfolio
      2. Target Markets
      3. Target End Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. Valeant Pharmaceuticals International, Inc.
      2. Taiwan Liposome Company, Ltd.
      3. Ocular Therapeutix, Inc.
      4. Graybug Vision Inc.
      5. Eyegate Pharma
      6. Clearside Biomedical, Inc.
      7. Alimera Sciences
      8. Eyegate Pharma
      9. Envisia Therapeutics
      10. Allergan, Plc.
  15. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Your data is 100% confidential & secure